Intact Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,600
Closed -$741K 244
2026
Q1
$741K Sell
8,600
-4,000
-32% -$359K 0.02% 230
2025
Q4
$1.1M Sell
12,600
-1,300
-9% -$98.7K 0.03% 214
2025
Q3
$796K Sell
13,900
-900
-6% -$51.8K 0.02% 227
2025
Q2
$873K Buy
14,800
+11,400
+335% +$737K 0.03% 232
2025
Q1
$249K Buy
+3,400
New +$281K 0.01% 258
2024
Q4
Sell
-4,000
Closed -$286K 333
2024
Q3
$286K Buy
4,000
+100
+3% +$7.06K 0.01% 245
2024
Q2
$267K Buy
+3,900
New +$233K 0.01% 248

Other funds holding GMED

Intact Investment Management's GMED Position: Q2 2026 in Review

Intact Investment Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 8,600 shares — an estimated $741K sold.

Intact Investment Management first reported a position in GMED in Q2 2024 and held it in 7 quarters. The position peaked at $1.1M in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Intact Investment Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Intact Investment Management sold 8,600 Globus Medical shares in Q2 2026, an estimated $741K.
  • Intact Investment Management first reported a position in Globus Medical in Q2 2024 and held it in 7 quarters.
  • Intact Investment Management's Globus Medical position peaked at $1.1M in Q4 2025.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.